EXOZYMES INC.
EXOZ · XNASCIK 2010788fmd_1CNQEECK4C1WN73ZE9VMDMQCM5Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2023 to Jun 30, 2026, 14 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 0 | – | – |
| Research and development | 1 | 2 | 4 |
| Compensation and benefits | 1 | 3 | 4 |
| Operating income | (2) | (6) | (10) |
| Other non-operating income (expense) | – | (0) | 0 |
| Income before taxes | (2) | (6) | (9) |
| Income tax expense | 0 | – | (0) |
| Net income from continuing operations | (2) | – | (9) |
| Net income | (2) | (6) | (9) |